| Literature DB >> 31930681 |
Enjie Liu1,2, Qiuzhi Zhou1, Ao-Ji Xie1, Xiaoguang Li1, Mengzhu Li1, Jinwang Ye1, Shihong Li1, Dan Ke1, Qun Wang1, Zhi-Peng Xu1, Li Li1, Ying Yang1, Gong-Ping Liu1, Xiao-Chuan Wang1, Hong-Lian Li3, Jian-Zhi Wang1,4.
Abstract
Overexpressing Tau counteracts apoptosis and increases dephosphorylated β-catenin levels, but the underlying mechanisms are elusive. Here, we show that Tau can directly and robustly acetylate β-catenin at K49 in a concentration-, time-, and pH-dependent manner. β-catenin K49 acetylation inhibits its phosphorylation and its ubiquitination-associated proteolysis, thus increasing β-catenin protein levels. K49 acetylation further promotes nuclear translocation and the transcriptional activity of β-catenin, and increases the expression of survival-promoting genes (bcl2 and survivin), counteracting apoptosis. Mutation of Tau's acetyltransferase domain or co-expressing non-acetylatable β-catenin-K49R prevents increased β-catenin signaling and abolishes the anti-apoptotic function of Tau. Our data reveal that Tau preserves β-catenin by acetylating K49, and upregulated β-catenin/survival signaling in turn mediates the anti-apoptotic effect of Tau.Entities:
Keywords: Tau; acetylation; acetyltransferase; anti-apoptosis; β-catenin
Mesh:
Substances:
Year: 2020 PMID: 31930681 PMCID: PMC7054687 DOI: 10.15252/embr.201948328
Source DB: PubMed Journal: EMBO Rep ISSN: 1469-221X Impact factor: 8.807